BioWorld MedTech

July 17, 2018

Stryker's flow diverter receives FDA thumbs up

Stryker Corp., of Kalamazoo, Mich., won FDA approval for the Surpass Streamline flow diverter to treat unruptured large and giant wide neck intracranial aneurysms. It is the second flow diverting stent to gain a green light in the U.S. Read More

FDA inks only 11 warnings to device makers to date in 2018

Researchers develop new imaging approach to detect cardiac stress, inflammation

Safe Orthopaedics raises $8.12M to boost its MIS spinal fracture treatment offerings

Prenatal gene therapy corrects fatal brain disease

Other news to note

Financings

Appointments and advancements

Product briefs

BioWorld MedTech's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...